Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · Real-Time Price · USD
4.180
-0.170 (-3.91%)
At close: Oct 7, 2025, 4:00 PM EDT
4.240
+0.060 (1.44%)
After-hours: Oct 7, 2025, 7:22 PM EDT

Clearside Biomedical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
4.171.668.231.3329.587.89
Upgrade
Revenue Growth (YoY)
-44.63%-79.77%519.89%-95.51%274.65%263.28%
Upgrade
Cost of Revenue
0.40.150.360.2--
Upgrade
Gross Profit
3.771.527.871.1229.587.89
Upgrade
Selling, General & Admin
11.2111.8111.8711.7711.6710.76
Upgrade
Research & Development
14.4218.5920.8519.6318.5415.07
Upgrade
Operating Expenses
25.6330.432.7231.430.225.83
Upgrade
Operating Income
-21.86-28.88-24.84-30.28-0.63-17.94
Upgrade
Interest Expense
-10.47-9.78-9.36-3.34--0.34
Upgrade
Interest & Investment Income
0.971.461.720.67--
Upgrade
Other Non Operating Income (Expenses)
4.362.85--0.010.06
Upgrade
EBT Excluding Unusual Items
-27-34.35-32.49-32.95-0.62-18.21
Upgrade
Other Unusual Items
----1-
Upgrade
Pretax Income
-27-34.35-32.49-32.950.38-18.21
Upgrade
Net Income
-27.71-34.35-32.49-32.950.38-18.21
Upgrade
Net Income to Common
-27.71-34.35-32.49-32.950.38-18.21
Upgrade
Shares Outstanding (Basic)
554443
Upgrade
Shares Outstanding (Diluted)
554443
Upgrade
Shares Change (YoY)
13.54%19.41%2.66%0.50%28.81%21.84%
Upgrade
EPS (Basic)
-5.44-6.98-7.88-8.210.10-5.87
Upgrade
EPS (Diluted)
-5.44-6.98-7.88-8.210.10-5.87
Upgrade
Free Cash Flow
-22.23-25.68-19.91-13.61-10.73-13.18
Upgrade
Free Cash Flow Per Share
-4.37-5.22-4.83-3.39-2.69-4.25
Upgrade
Gross Margin
90.47%91.05%95.68%84.63%100.00%100.00%
Upgrade
Operating Margin
-524.63%-1735.70%-302.02%-2281.61%-2.12%-227.20%
Upgrade
Profit Margin
-665.22%-2064.42%-394.91%-2482.82%1.27%-230.68%
Upgrade
Free Cash Flow Margin
-533.65%-1542.97%-242.06%-1025.70%-36.29%-166.90%
Upgrade
EBITDA
-21.53-28.66-24.78-30.13-0.45-17.76
Upgrade
EBITDA Margin
-----1.52%-224.92%
Upgrade
D&A For EBITDA
0.320.230.070.150.180.18
Upgrade
EBIT
-21.86-28.88-24.84-30.28-0.63-17.94
Upgrade
EBIT Margin
-----2.12%-227.20%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q